Forskaren - Hagastaden's Innovation Cluster
It all started with a vision: to create a world-leading environment for innovation where academia, healthcare, industry, entrepreneurs and investors could come together to accelerate the future of health. Today, Forskaren is the heart of Hagastaden – one of the world’s most dynamic Life Science innovation districts and a destination where people, ideas and organizations come together to drive progress. Located at Hagaplan, alongside Karolinska University Hospital, Karolinska Institutet, and SciLifeLab, Forskaren sits at the center of a globally unique concentration of research, healthcare, talent and innovation.

The place for Life Science in Stockholm
The building brings together approximately 20 tenants spanning the entire Life Science ecosystem – from pioneering biotech and medtech companies to research organizations, investors, healthcare actors, and support functions. By creating an environment where people, ideas, and expertise meet every day, Forskaren accelerates innovation and enables new partnerships that can transform the future of health and medicine.
Offices for innovators
Attract the right talent with room to grow and creative solutions.
Forskaren offers a wide variety of ways to work and play, providing 24,000 square meters of flexible workspaces with offices and lab-spaces. We believe in long-term commitments, sustainable solutions, and a co-creating community – working together towards new innovations in life science and health tech.
Science for everyone
Open doors, open minds
The entrance floor in Forskaren is open to the public, offering events, restaurants and exhibitions. With The Cell, Urban Deli and Elekta's showroom the public is invited to join Hagastaden's new living room. Forskaren is a place where everyone curious about life science is welcome.
Hagastaden in numbers
6000 New Homes
50 000 Workplaces
Investments 70 BN SEK

Hagastaden is a natural hub for research and innovation. At AstraZeneca’s Nordic commercial organization, based in Forskaren, we work to ensure that research benefits patients in Sweden and across the Nordic region.
Emelie AntoniCountry president Nordic & Sweden AstraZeneca

